51 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd.
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata
424B5
URGN
UroGen Pharma Ltd.
18 Jun 24
Prospectus supplement for primary offering
5:05pm
of our clinical development efforts, the timing and progress of any partnering efforts, and the competitive environment for our product(s) and product
424B5
URGN
UroGen Pharma Ltd.
17 Jun 24
Prospectus supplement for primary offering
4:19pm
, the timing and progress of our clinical development efforts, the timing and progress of any partnering efforts, and the competitive environment for our product
8-K
EX-99.1
gir61nwieakcxqoyi qh
11 Aug 22
UroGen Pharma Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
8:11am